MED13 variants were subsequently described in patients with ASD (Iossifov et al., 2014; Rk et al., 2017) and, recently, missense or truncating variants were identified in thirteen patients presenting with developmental delay, ID, and speech disorders (Snijders Blok et al., 2018). This evidence concerns the gene MED13 and Global developmental delay.